key: cord-0894272-zl5x0qoz authors: Singh, Rahul; Bhardwaj, Vijay Kumar; Purohit, Rituraj title: Potential of turmeric-derived compounds against RNA‐dependent RNA polymerase of SARS‐CoV‐2: An in-silico approach date: 2021-10-22 journal: Comput Biol Med DOI: 10.1016/j.compbiomed.2021.104965 sha: 67977402315806540307b6916cce8566af2c2da0 doc_id: 894272 cord_uid: zl5x0qoz The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is the causative agent of the COVID-19 pandemic. Currently, there are no particular antivirals available to battle with COVID-19. The RNA-dependent RNA polymerase (RdRp) has emerged as a novel drug target due to its essential role in virus replication. In this study, turmeric-derived compounds were chosen and subjected to in-silico analysis to evaluate their binding affinity against the RdRp-RNA complex of SARS-CoV-2. Our in-silico approach included the analysis of protein-ligand interactions by molecular docking and molecular dynamics simulations, followed by free energy calculations by molecular mechanics Poisson-Boltzmann surface area analysis. Curcumin and diacetylcurcumin showed stability and good binding affinity at the active site of the SARS-CoV-2 RdRp-RNA complex. Furthermore, to validate the potency of selected compounds, we compared them with Favipiravir and Remdesivir antiviral drugs from our previous analysis on targeting tea bioactive molecules to inhibit RdRp-RNA complex. The comparative analysis revealed that the selected compounds showed higher potential to be developed as RdRp-RNA inhibitors than antiviral medicines Remdesivir and Favipiravir. However, these compounds need to be further validated by in-vitro and in-vivo investigations. Nsp8, and primer-template RNA. We used the Pubchem database to acquire the six turmeric-114 derived compounds [15, 16] . Compounds were prepared for molecular docking study by 115 optimizing the ligand geometry of each compound through Gaussian16 DFT minimization 116 protocols [17] . We adopted the "prepare protein" function of Discovery studio client 2018 to 117 prepare missing loops of the protein [18] . binding styles from docking results. GROMACS was used to evaluate the best-docked poses by 132 employing GROMOS96 43a1 forcefield [20] . PRODRG server used to produce ligand topologies. 133 Simulations were carried out in a water box using a water model and neutralized the system with 134 counter-ions. The steepest descent (energy minimization) algorithm was applied to avoid wrong 135 associations from the original structures, and they have then subjected to NPT and NVT 136 equilibration. We performed the NVT ensemble with a V-rescale thermostat at 300 K for 1 ns and 137 the NPT ensemble at 1 bar pressure with Parrinello-Rahman barostat for 1 ns [21] . The geometry 138 J o u r n a l P r e -p r o o f of the water molecules and bond constraints monitored using SETTLE and LINCS algorithms 139 [22] . Particle Mesh Ewald (PME) was adopted to estimate long-range electrostatic and short-140 range non-bonded interactions [23] . We streamed MD simulations on the equilibrated NPT 141 ensembles of every system. We used the Molecular Mechanics Poisson-Boltzmann Surface Area 142 (MM-PBSA) procedure for every system and estimated the outcomes based on protein-ligand total 143 energy [24] . 144 In the current study, molecular docking was adopted to predict the binding between six turmeric-154 Moreover, the residues Asp623, Val557, and Asp761 showed Van der Waal interactions. 171 Diacetylcurcumin also interacted with the primer and template RNA strands by carbon-hydrogen 172 bonds, π-π stacked, and π-anion interactions. The residues Asp623, Ser682, and Asn691 allows To categorize potent inhibitors against the RdRp-RNA complex of SARS-CoV-2, we compared our 227 selected turmeric-derived compounds with the antiviral medicines Favipiravir and Remdesivir. The 228 interacting residues and the binding free energies of Favipiravir and Remdesivir were analyzed in 229 our previous study [31] . On comparing the results, curcumin and diacetylcurcumin showed good 230 interactions with important residues of the NTP entry channel and catalytic center of RdRp than 231 antiviral medicines Favipiravir and Remdesivir. Moreover, we also compared binding free energies 232 of selected compounds with Favipiravir and Remdesivir (Table S1) Bis Structural basis for active site closure by the poliovirus RNA-299 dependent RNA polymerase Remdesivir and SARS-CoV-2: Structural requirements at both 303 nsp12 RdRp and nsp14 Exonuclease active-sites Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus 307 (2019-nCoV) in vitro First Case of 2019 Novel Coronavirus in the United States A review on antibacterial, antiviral, and antifungal activity of curcumin Curcumin inhibits Zika and 318 chikungunya virus infection by inhibiting cell binding Biochemical Composition of Curcuma longa 321 L. Accessions The chemistry of curcumin: From extraction to therapeutic agent Efficient Geometry Minimization and Transition Structure 326 Optimization Using Interpolated Potential Energy Surfaces and Iteratively Updated Hessians CHARMM general force field: A force 332 field for drug-like molecules compatible with the CHARMM all-atom additive biological 333 force fields 335 GROMACS: Fast, flexible, and free Polymorphic transitions in single crystals: A new molecular 338 dynamics method LINCS: A Linear Constraint Solver 340 for molecular simulations Particle mesh Ewald: An N·log(N) method for Ewald sums 343 in large systems G-mmpbsa -A GROMACS tool for high-throughput MM-345 PBSA calculations Curcumin as a Potential Treatment for COVID-19 Activity of phytochemical constituents 350 of Curcuma longa (turmeric) and Andrographis paniculata against coronavirus (COVID-19): 351 an in silico approach, Futur Phytochemical 354 Moieties From Indian Traditional Medicine for Targeting Dual Hotspots on SARS Spike Protein: An Integrative in-silico Approach Identification of potential plant 358 bioactive as SARS-CoV-2 Spike protein and human ACE2 fusion inhibitors Structure of 361 replicating SARS-CoV-2 polymerase Structure of the RNA-366 dependent RNA polymerase from COVID-19 virus, Science (80-. ) Bioactive 369 molecules of Tea as potential inhibitors for RNA-dependent RNA polymerase of SARS-CoV-370 2 Explicit-solvent molecular dynamics 372 simulations revealed conformational regain and aggregation inhibition of I113T SOD1 by 373 Himalayan bioactive molecules Evaluation of acridinedione analogs as potential 376 SARS-CoV-2 main protease inhibitors and their comparison with repurposed anti-viral drugs A computational approach for rational discovery 379 of inhibitors for non-structural protein 1 of SARS-CoV-2 An in-silico 382 evaluation of different bioactive molecules of Tea for their inhibition potency against non 383 structural protein-15 of SARS-CoV-2 In-silico evaluation of bioactive 386 compounds from tea as potential SARS-CoV-2 nonstructural protein 16 inhibitors Identification of 389 bioactive molecules from tea plant as SARS-CoV-2 main protease inhibitors Natural plant 392 products as potential inhibitors of RNA dependent RNA polymerase of Severe Acute 393 Respiratory Syndrome Coronavirus-2 Computational molecular docking and virtual 396 screening revealed promising SARS-CoV-2 drugs In silico investigation on the inhibitory effect of fungal secondary metabolites on 400 RNA dependent RNA polymerase of SARS-CoV-II: A docking and molecular dynamic 401 simulation study Structural insights 404 on the interaction potential of natural leads against major protein targets of SARS-CoV-2: 405 Molecular modelling, docking and dynamic simulation studies Backbone RMSDs are shown as a function of time for the RdRp-RNA of SARS-CoV-2